Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIDXXIdexx Laboratories
FinDog View：Bullish
LLYLilly (Eli)
FinDog View：Bullish
| Metric | IDXX | LLY |
|---|
| Close | 551.21 | 1,417.54 |
| Market Cap | $43.9B | $1.34T |
| 1M | +5.56% | +22.51% |
| P/E (TTM) | 38.9 | 50.2 |
| Forward P/E | 32.2 | 26.3 |
| P/E 5-Yr Percentile | 7 | 28 |
| P/S | 9.8 | 16.8 |
| P/B | 27.5 | 39.6 |
| Dividend Yield | — | 0.75% |
| Latest Quarter Revenue | $1.2B | $24.4B |
| Revenue YoY | +9.7% | +38.6% |
| Gross Margin | 64.0% | 83.9% |
| Latest Quarter EPS | 4.27 | 7.22 |
| Avg Post-Earnings Move | ±1.8% | ±3.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.68% | 0.88% |
| 90-Day Net Insider Buying | −$1.2M | −$16.0M |
IDXX · Revenue, Last 8 Quarters ($B)
LLY · Revenue, Last 8 Quarters ($B)
